334 related articles for article (PubMed ID: 19211778)
1. SCAN--a high-throughput assay for detecting small molecule binding to RNA targets.
Baugh C; Wang S; Li B; Appleman JR; Thompson PA
J Biomol Screen; 2009 Mar; 14(3):219-29. PubMed ID: 19211778
[TBL] [Abstract][Full Text] [Related]
2. SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.
Seth PP; Miyaji A; Jefferson EA; Sannes-Lowery KA; Osgood SA; Propp SS; Ranken R; Massire C; Sampath R; Ecker DJ; Swayze EE; Griffey RH
J Med Chem; 2005 Nov; 48(23):7099-102. PubMed ID: 16279767
[TBL] [Abstract][Full Text] [Related]
3. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
[TBL] [Abstract][Full Text] [Related]
4. Assay Optimization and Screening of RNA-Protein Interactions by AlphaScreen.
Mills NL; Shelat AA; Guy RK
J Biomol Screen; 2007 Oct; 12(7):946-55. PubMed ID: 17942787
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptase.
Nakayama GR; Bingham P; Tan D; Maegley KA
Anal Biochem; 2006 Apr; 351(2):260-5. PubMed ID: 16527235
[TBL] [Abstract][Full Text] [Related]
7. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
[TBL] [Abstract][Full Text] [Related]
8. A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening.
Hajduk PJ; Betz SF; Mack J; Ruan X; Towne DL; Lerner CG; Beutel BA; Fesik SW
J Biomol Screen; 2002 Oct; 7(5):429-32. PubMed ID: 14599358
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
[TBL] [Abstract][Full Text] [Related]
10. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation.
Marine S; Zamiara E; Smith ST; Stec EM; McGarvey J; Kornienko O; Jiang G; Wong KK; Stack JH; Zhang BB; Ferrer M; Strulovici B
Anal Biochem; 2006 Aug; 355(2):267-77. PubMed ID: 16797469
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.
Chung RT; Kaplan LM
Biochem Biophys Res Commun; 1999 Jan; 254(2):351-62. PubMed ID: 9918842
[TBL] [Abstract][Full Text] [Related]
12. A conserved RNA structure within the HCV IRES eIF3-binding site.
Collier AJ; Gallego J; Klinck R; Cole PT; Harris SJ; Harrison GP; Aboul-Ela F; Varani G; Walker S
Nat Struct Biol; 2002 May; 9(5):375-80. PubMed ID: 11927954
[TBL] [Abstract][Full Text] [Related]
13. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
14. [Approach to identifying the functionally important segments of RNA, based on complementation-addressed modification].
Malygin AA; Graĭfer DM; Laletina ES; Shatskiĭ IN; Karpova GG
Mol Biol (Mosk); 2003; 37(6):1027-34. PubMed ID: 14714498
[TBL] [Abstract][Full Text] [Related]
15. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
16. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors.
Delle Fratte S; Piubelli C; Domenici E
J Biomol Screen; 2002 Dec; 7(6):541-6. PubMed ID: 14599352
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput robotic fluorescence-based assay for HsEg5 inhibitor screening.
Zhang B; Senator D; Wilson CJ; Ng SC
Anal Biochem; 2005 Oct; 345(2):326-35. PubMed ID: 16125662
[TBL] [Abstract][Full Text] [Related]
19. [Molecular environment of the IIId subdomain of the IRES element of hepatitits C virus RNA on the human 40S ribosomal subunit].
Babaĭlova ES; Graĭfer DM; Malygin AA; Shatskiĭ IN; Shtal I; Karpova GG
Bioorg Khim; 2009; 35(1):103-12. PubMed ID: 19377528
[TBL] [Abstract][Full Text] [Related]
20. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
